Skip to Content

Inovio Pharmaceuticals Inc INO

Morningstar Rating
$11.03 −0.73 (6.21%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

INO is trading at a 65% discount.
Price
$11.80
Fair Value
$79.00
Uncertainty
Extreme
1-Star Price
$815.83
5-Star Price
$7.78
Economic Moat
Rmyq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$11.76
Day Range
$10.8211.90
52-Week Range
$3.8914.75
Bid/Ask
$10.82 / $11.05
Market Cap
$257.78 Mil
Volume/Avg
270,074 / 487,797

Key Statistics

Price/Earnings (Normalized)
Price/Sales
306.75
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
122

Comparables

Valuation

Metric
INO
MRNA
002007
Price/Earnings (Normalized)
39.8725.86
Price/Book Value
2.242.953.01
Price/Sales
306.756.066.38
Price/Cash Flow
17.52
Price/Earnings
INO
MRNA
002007

Financial Strength

Metric
INO
MRNA
002007
Quick Ratio
3.473.21
Current Ratio
3.603.42
Interest Coverage
−116.15−113.82
Quick Ratio
INO
MRNA
002007

Profitability

Metric
INO
MRNA
002007
Return on Assets (Normalized)
−46.31%−20.12%
Return on Equity (Normalized)
−66.32%−26.85%
Return on Invested Capital (Normalized)
−59.56%−26.68%
Return on Assets
INO
MRNA
002007
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRZnllkphzYdl$564.6 Bil
REGN
Regeneron Pharmaceuticals IncKcztlqjQlgdp$102.8 Bil
VRTX
Vertex Pharmaceuticals IncMxhdyfzXtgtyv$102.5 Bil
MRNA
Moderna IncTmlgqbjlmVwc$41.0 Bil
ARGX
argenx SE ADRDmbnqqsJwht$22.8 Bil
BNTX
BioNTech SE ADRKyqfffcNrqs$21.7 Bil
ALNY
Alnylam Pharmaceuticals IncRxdsqykghJjzjjx$18.8 Bil
BMRN
Biomarin Pharmaceutical IncLxffppbfvWbxrl$17.4 Bil
RPRX
Royalty Pharma PLC Class APnbwlfjmWflnsn$12.6 Bil
INCY
Incyte CorpFryvqvmpHjhhd$12.1 Bil

Sponsor Center